Navigation Links
Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
Date:7/22/2009

KENILWORTH, N.J., July 22 /PRNewswire-FirstCall/ -- Schering-Plough today announced that a New Drug Application (NDA) for a fixed-dose combination of mometasone furoate and formoterol fumarate has been filed in the United States and accepted for review by the U.S. Food and Drug Administration (FDA). Schering-Plough is seeking marketing approval from the FDA of the mometasone furoate/formoterol fumarate combination for the maintenance treatment of asthma in patients 12 years of age and older.

Mometasone furoate/formoterol fumarate combines the active ingredients of an inhaled corticosteroid, ASMANEX((R) )(mometasone furoate inhalation powder), with the long-acting beta2-agonist, FORADIL((R)) (formoterol fumarate inhalation powder), administered via a single metered-dose inhaler. Schering-Plough has exclusive worldwide rights for the development and commercialization of the mometasone furoate and formoterol furmarate fixed-dose combination.

"We are pleased to announce the U.S. filing of the fixed-dose combination of mometasone furoate and formoterol fumarate," said Thomas P. Koestler, Ph.D., executive vice president and president, Schering-Plough Research Institute. "If approved by the FDA, the mometasone fuorate/formoterol combination would represent an important additional treatment option for physicians and their patients and further strengthen Schering-Plough's portfolio of respiratory products."

Combination products containing inhaled corticosteroids and long-acting beta2-agonists are the largest segment of the worldwide market for asthma and chronic obstructive pulmonary disease (COPD) medications, in terms of dollar sales (1). The fixed-dose combination of mometasone furoate and formoterol fumarate for the treatment of asthma in patients younger than 12 years of age and for use in COPD is currently in Phase III development.

Schering-Plough is an innovation-dri
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
4. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
8. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
9. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
11. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...PRNewswire/ -- Riverain Medical announced today th...adian medical imaging distributor Christie Group t...d Chest Xray CAD. The exclusive agreement will bri...to the Canadian market through Christie Group,s es...iew Enhanced Chest Imaging increases the clarity o...
(Date:11/19/2009)...PRNewswire/ -- As the seasons change, another seas...e on preparing yourself. ,, Listen to this repo...at: ,, http://inr.mediaseed.tv/oneClip_C/?fe...link is a division of The NewsMarket. Registered ...s and photos at http://www.thenewsmarket.com . ...
(Date:11/19/2009).... 19 Breast-Specific Gamma Imaging...gnized and endorsed by two highly esteemed organiz...ciety of Breast Imaging (SBI) and the American Col...s supporting the further application of this break... of breast cancer. ,, "These endorsements reinf...
Breaking Medicine Technology:Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 2Esteemed Endorsements Recognize Promising Future of Breast-Specific Gamma Imaging (BSGI) 3Stimulus grant of nearly 249 million to UC San Diego funds big study of young brains 10390 1Stimulus grant of nearly 249 million to UC San Diego funds big study of young brains 10390 2Stimulus grant of nearly 249 million to UC San Diego funds big study of young brains 10390 3Acetaminophen May Weaken Effectiveness of Kids Vaccines 59592 1Acetaminophen May Weaken Effectiveness of Kids Vaccines 59592 2Suicidal Thoughts May Vary by Antidepressant 59590 1
(Date:11/22/2009)...g ahead can help keep eating under control, expert...s) -- The holiday season means you,ll be faced wit...hile some people simply give in and eat too much, ...t there are ways to navigate between overindulgenc...ager of Nutrition Consult Services at Brigham and ...
(Date:11/22/2009)... Man & Machine post You Tube...us the competition , Land...board users interested in learning what a really r...ne into “Really Cool Keyboard vs Washable Co...The film demonstrates how the premium, Really Cool...
(Date:11/21/2009)..., WASHINGTON, Nov. 21 /PRNewswire-USNewswire/ -...ement after the Senate voted to begin full debate ...go: http://www.newscom.com/cgi-bin/prnh/20080519/...historic step on the road to enacting health insur...dle, senators will now have an opportunity to deba...
(Date:11/21/2009)... , WASHINGTON, Nov. 21 /PRNewswire-USNewswire/ ...eliminate onchocerciasis (river blindness) in the ...of the disease in recent years, as evidenced by a ...g mass drug administration in six endemic countrie... meeting of the American Society of Tropical Medic...
(Date:11/21/2009)... NH based medical credentialing ... its industry to form a partnerhsip with Amerinet,...This partnership will help to transform quality ca... (Vocus) November 21, 2009 -- ISG Group, ...unced a new agreement with Amerinet Inc., a leadin...
Breaking Medicine News(10 mins):Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2
...age the Facilities, ATLANTA, June 12 Formation C...ment to purchase Haven Healthcare, a long-term car...theastern states. Genesis,HealthCare will manage a...g approvals, and other customary conditions.,In ad...
... June 2008: Ovarian function can be preserved and...systemic lupus erythematosus (SLE) when treated wi...hemotherapy drug, followed by the immunosuppressan...n Paris, France. , SLE, a complex and unpredicta...
...e Adds More Than 10 million PubMed Abstracts, Enab...ier and Faster than with Curren...the Web,s leading general,semantic search engine, ...maintained by the U.S. National Library of,Medicin...
...# 1 Selling Protein*, DESIGNER WHEY Is ...D, Calif., June 12 Proper hydration is crucial,to... optimal body health.,Water is the key resource th...ked drinks. PROTEIN BLITZ drinks,will be available...
... Rochester,Medical Corporation (Nasdaq: ROCM ) to...formance Award, presented by the Premier healthcar... Medical is one of 54 of more than 800 Premier con...pectations., Commenting on the award, Anthony J. ...
...werful super computer to mimic the part of the bra...etter understand what goes wrong after brain damag...The University of Manchester have teamed up with c...ful than a standard PC. , Dubbed ,Chatter Box, th...
Other Medicine News:Health News:Formation Capital to Purchase Haven Healthcare 2Health News:Ovarian function and fertility preserved in women with severe systemic lupus erythematosus 2Health News:hakia Boosts Health and Medical Search Capabilities with PubMed 2Health News:DESIGNER WHEY(R) Launches New PROTEIN BLITZ(TM) Drinks: Protein Like You've Never Tasted Before 2Health News:DESIGNER WHEY(R) Launches New PROTEIN BLITZ(TM) Drinks: Protein Like You've Never Tasted Before 3Health News:Rochester Medical Honored by Premier Healthcare Alliance for Exceeding Performance Expectations 2Health News:Rochester Medical Honored by Premier Healthcare Alliance for Exceeding Performance Expectations 3Health News:'Chatter Box' computer will unravel the science of language 2
... synthetic bone filler tailored for slow resorbtio...apatite (HAP), its composition mimics that of huma...cture of Bi-Ostetic to enhance bone regeneration. .... The spongy Bi-Ostetic bioceramic granules with t...
PACE 101 H
TAU Temporary Lead with Stylet
TME 228 C
Medicine Products: